Bupropion Hydrochloride

Product NDC
72162-1526
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
bupropion hydrochloride
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA207479
Marketing category
ANDA
Substance
BUPROPION HYDROCHLORIDE
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
72162-1526-330 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72162-1526-3) 20170412NoHistorical

Related DailyMed Labels

Set IDTitleManufacturerEffective dateTypeVersion
cefaaa17-f79a-4ba6-8f97-a59f60e07b75These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE extended-release tablets (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE extended-release tablets (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985Bryant Ranch Prepack2026-03-31HUMAN PRESCRIPTION DRUG LABEL104